Nearly 15 percent of patients diagnosed with colorectal cancer were younger than 50, the age at which screening recommendations begin.
Jan 25, 2016
0
8
An increasing number of men diagnosed with low-risk prostate cancer are opting for active surveillance - closely monitoring their cancer - rather than aggressive treatment to avoid the debilitating potential side effects ...
Dec 1, 2015
0
3
Treating both low-density lipoprotein (LDL), or "bad," cholesterol with statins and blood pressure with calcium channel antagonists reduces harmful coronary plaque, according to a new study presented today as a late-breaking ...
May 11, 2015
0
10
A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.
Mar 16, 2015
0
29
(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.
Mar 11, 2015
0
6
National guidelines recommend that men with low- and intermediate-risk prostate cancer who have life expectancies of fewer than 10 years should not be treated with radiation or surgery, since they are unlikely to live long ...
Dec 11, 2014
0
0
Adhering to a Mediterranean-style diet may significantly reduce the risk of developing chronic kidney disease, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology ...
Oct 30, 2014
0
0
A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research published ahead of print in the journal Molecular and Cellular Biology.
Aug 25, 2014
0
0
Most physicians would choose a do-not-resuscitate or "no code" status for themselves when they are terminally ill, yet they tend to pursue aggressive, life-prolonging treatment for patients facing the same prognosis, according ...
May 28, 2014
0
0
(HealthDay)—For men with early-stage prostate cancer, the cancer-specific survival benefit associated with aggressive prostate cancer treatment is reduced with increasing comorbidity, according to a study published online ...
May 21, 2014
0
0
